P2.12-08 Network Meta-Analysis of Angiogenesis Inhibitors on Survival of Patients with Small Cell Lung Cancer

Volume: 13, Issue: 10, Pages: S793 - S793
Published: Oct 1, 2018
Abstract
This network meta-analysis aimed at providing a comprehensive evaluation of the effects of angiogenic inhibitors on small cell lung cancer by using network meta-analysis. The relative efficacy of angiogenesis inhibitors vandetanib (Van), bevacizumab (Bev), Rh-endostatin (End), sunitinib (Sun) and thalidomide (Tha) was evaluated by conducting a network meta-analysis of progression-free survival and overall survival. Nine phase II-III RCTs...
Paper Details
Title
P2.12-08 Network Meta-Analysis of Angiogenesis Inhibitors on Survival of Patients with Small Cell Lung Cancer
Published Date
Oct 1, 2018
Volume
13
Issue
10
Pages
S793 - S793
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.